Indeed, creating a ‘smart investment strategy’ offers wide-ranging benefits – healthcare providers can innovate, patients ...

At ESMO 2025, pharmaphorum had the pleasure of speaking with Michael Lahn, Chief Medical Officer at iOnctura, a ...

Five AI-based technologies that can be used during a colonoscopy exam to help detect the early signs of bowel cancer have ...

Merck KGaA has teamed up with Flagship Pioneering's Valo Health on an ambitious project to apply AI to the discovery of novel ...

A mental health campaigner has condemned the "stunning silence" from mainstream media in the UK after the first-ever men's ...

The FDA has given accelerated approval to Bayer for oral HER2 tyrosine kinase inhibitor sevabertinib as a second-line treatment for advanced HER2-mutant non-small cell lung cancer (NSCLC), allowing it ...

Alongside scientific innovation, ESMO 2025 emphasised the need for global collaboration in regulatory alignment and clinical ...

Medscape has joined the ranks of companies offering a generative AI chatbot to support clinical decision-making and help ease ...

Johnson & Johnson has added to the flurry of M&A deals in pharma with an agreement to buy US biotech Halda Therapeutics and its RIPTAC platform for generating small-molecule cancer drugs. J&J said it ...

A multibillion-dollar partnership between AbbVie and Genmab risks being soured by a lawsuit claiming misappropriation of trade secrets. Specifically, it focuses on the use of disaccharides to improve ...

CDER director George Tidmarsh will now also take responsibility for CBER at the FDA. The FDA has moved swiftly to fill the void left by Vinay Prasad's resignation as director of the Center for ...

With the much-anticipated release today of the Make America Healthy Again report and strategy document, the US Department of Health and Human Services under Robert F Kennedy Jr also announced a new ...